Is Suposed Appropriate for Atopic Dermatitis?
I cannot provide a definitive answer because "suposed" does not correspond to any recognized medication name for atopic dermatitis. This appears to be either a misspelling or an incomplete medication name.
Possible Interpretations
If you meant one of these FDA-approved medications for atopic dermatitis, here are the answers:
If you meant "Dupilumab" (Dupixent):
Yes, dupilumab is highly appropriate and represents the first-line systemic therapy for moderate-to-severe atopic dermatitis in adults. 1 All guideline workgroup members surveyed favored dupilumab as their preferred first-line systemic agent, and it has an excellent safety track record with more than 5 years of clinical use without major emergent safety concerns. 1
If you meant a topical therapy:
Several topical agents are FDA-approved and strongly recommended for atopic dermatitis:
Roflumilast cream 0.15%: Strongly recommended for mild-to-moderate AD with high-certainty evidence showing significant improvements in disease severity and pruritus at 4 weeks, with excellent tolerability 2
Ruxolitinib cream: A topical JAK inhibitor that is strongly recommended and among the most effective topical treatments 3, 4
Tacrolimus ointment (0.03% and 0.1%): High-certainty evidence supports its use, improving multiple AD outcomes 4
Pimecrolimus: Among the most effective topical treatments with high-certainty evidence for improving 6 of 7 AD outcomes 4
Please Clarify
To provide you with the specific recommendation you need, please verify the correct spelling of the medication name. Common atopic dermatitis medications include: dupilumab, tralokinumab, lebrikizumab, nemolizumab, upadacitinib, abrocitinib, baricitinib, roflumilast, ruxolitinib, tacrolimus, or pimecrolimus.